Incidence of 5' bcl-2 rearrangement in patients with B cell chronic lymphocytic leukemia from India.

[1]  L. Rassenti,et al.  Autoantigen inhibits apoptosis of a human B cell leukemia that produces pathogenic rheumatoid factor. , 1993, Journal of immunology.

[2]  H. Nishimura,et al.  H‐2Z Homozygous New Zealand Mice as a Model for B‐Cell Chronic Lymphocytic Leukemia: Elevated bcl‐2 Expression in CD5 B Cells at Premalignant and Malignant Stages , 1993, Japanese journal of cancer research : Gann.

[3]  H. Dohy,et al.  Japanese B cell chronic lymphocytic leukaemia: a cytogenetic and molecular biological study , 1993, British journal of haematology.

[4]  John Calvin Reed,et al.  bcl-2 Gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia , 1993 .

[5]  M. Morrison,et al.  Lack of 5' BCL2 rearrangements in B-cell leukemia. , 1993, Cancer genetics and cytogenetics.

[6]  K. Bhatia,et al.  Molecular characterization of scl rearrangements in T-cell all from India and egypt. , 1993, International journal of oncology.

[7]  L. Moretti,et al.  bcl-2 gene expression in hematopoietic cell differentiation , 1992 .

[8]  M Schena,et al.  Growth- and differentiation-associated expression of bcl-2 in B-chronic lymphocytic leukemia cells. , 1992, Blood.

[9]  M. Raffeld,et al.  Oncogene rearrangements in chronic B-cell leukemia. , 1991, Blood.

[10]  T. Kipps,et al.  Preferential linkage of bcl-2 to immunoglobulin light chain gene in chronic lymphocytic leukemia , 1990, The Journal of experimental medicine.

[11]  H. Gralnick,et al.  Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group. , 1989, Journal of clinical pathology.

[12]  W. Plunkett,et al.  Apoptosis in chronic lymphocytic leukemia , 1994 .